| Name | Title | Contact Details |
|---|
Purpose Legal is a prominent provider of legal support services, focusing on eDiscovery, document review, and legal technology solutions. Founded by attorneys over a decade ago and based in Austin, TX, the company aims to enhance the efficiency of legal services through a skilled and diverse team. Purpose Legal is recognized for its commitment to diversity, with 89% of its workforce representing various backgrounds and 63% being female. The company offers a comprehensive range of services tailored to corporate legal departments and law firms. These services include secure eDiscovery solutions, thorough document reviews, and customized legal technology solutions. Purpose Legal also provides litigation support, information governance, data breach discovery, and commercial contract review. Additionally, the company applies data science techniques to improve legal operations and decision-making. Purpose Legal is trusted by a wide array of clients, including multinational corporations and government entities, and has received several prestigious certifications, ensuring high standards of quality and security.
Miller Engineerings design and consulting team provides over 100 cumulative years of construction and design experience, which will ensure the success of your project.
Bimeda is an Ireland-based company that develops, manufactures and markets veterinary and animal care products.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
The Volkswagen Group with its headquarters in Wolfsburg is one of the worlds leading automobile manufacturers and the largest carmaker in Europe. The Group is made up of ten brands from seven European countries: Volkswagen, Volkswagen Nutzfahrzeuge, ŠKODA, SEAT, CUPRA, Audi, Lamborghini, Bentley, Porsche and Ducati. Our group sells vehicles in 153 countries and operates 114 production plants worldwide. Each working day, around 675,000 employees worldwide produce cars, are involved in vehicle-related services or work in the other fields of business. Our goal is to make mobility sustainable for us and for future generations. Our promise: With electric drive, digital networking and autonomous driving, we make the automobile clean, quiet, intelligent and safe. At the same time, our core product becomes even more emotional and offers a completely new driving experience. It is also becoming part of the solution when it comes to climate and environmental protection. In this way, the car can continue to be a cornerstone of contemporary, individual and affordable mobility in the future. #Shapingmobility Imprint & Legal: http://vw.de/legal-notice DAT: http://vw.de/dat